These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 38084656)
1. Supplementing clinical lactation studies with PBPK modeling to inform drug therapy in lactating mothers: Prediction of primaquine exposure as a case example. Pan X; Abduljalil K; Almond LM; Pansari A; Yeo KR CPT Pharmacometrics Syst Pharmacol; 2024 Mar; 13(3):386-395. PubMed ID: 38084656 [TBL] [Abstract][Full Text] [Related]
2. Primaquine Pharmacokinetics in Lactating Women and Breastfed Infant Exposures. Gilder ME; Hanpithakphong W; Hoglund RM; Tarning J; Win HH; Hilda N; Chu CS; Bancone G; Carrara VI; Singhasivanon P; White NJ; Nosten F; McGready R Clin Infect Dis; 2018 Sep; 67(7):1000-1007. PubMed ID: 29590311 [TBL] [Abstract][Full Text] [Related]
3. Population pharmacokinetic modelling of primaquine exposures in lactating women and breastfed infants. Wattanakul T; Gilder ME; McGready R; Hanpithakpong W; Day NPJ; White NJ; Nosten F; Tarning J; Hoglund RM Nat Commun; 2024 May; 15(1):3851. PubMed ID: 38719803 [TBL] [Abstract][Full Text] [Related]
4. Physiologically Based Pharmacokinetic Modeling to Determine the Impact of CYP2B6 Genotype on Efavirenz Exposure in Children, Mothers and Breastfeeding Infants. Pan X; Rowland Yeo K Clin Pharmacol Ther; 2023 Jul; 114(1):182-191. PubMed ID: 37078251 [TBL] [Abstract][Full Text] [Related]
6. Informing a Comprehensive Risk Assessment of Infant Drug Exposure From Human Milk: Application of a Physiologically Based Pharmacokinetic Lactation Model for Sotalol. Pressly MA; Schmidt S; Guinn D; Liu Z; Ceresa C; Samuels S; Madabushi R; Florian J; Fletcher EP J Clin Pharmacol; 2023 Jun; 63 Suppl 1():S106-S116. PubMed ID: 37317500 [TBL] [Abstract][Full Text] [Related]
7. Pathway-specific inhibition of primaquine metabolism by chloroquine/quinine. Fasinu PS; Tekwani BL; Avula B; Chaurasiya ND; Nanayakkara NP; Wang YH; Khan IA; Walker LA Malar J; 2016 Sep; 15(1):466. PubMed ID: 27618912 [TBL] [Abstract][Full Text] [Related]
8. Determination of Cytochrome P450 Isoenzyme 2D6 (CYP2D6) Genotypes and Pharmacogenomic Impact on Primaquine Metabolism in an Active-Duty US Military Population. Spring MD; Sousa JC; Li Q; Darko CA; Morrison MN; Marcsisin SR; Mills KT; Potter BM; Paolino KM; Twomey PS; Moon JE; Tosh DM; Cicatelli SB; Froude JW; Pybus BS; Oliver TG; McCarthy WF; Waters NC; Smith PL; Reichard GA; Bennett JW J Infect Dis; 2019 Oct; 220(11):1761-1770. PubMed ID: 31549155 [TBL] [Abstract][Full Text] [Related]
9. Vitamin D supplementation for term breastfed infants to prevent vitamin D deficiency and improve bone health. Tan ML; Abrams SA; Osborn DA Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013046. PubMed ID: 33305822 [TBL] [Abstract][Full Text] [Related]
10. Prediction of basic drug exposure in milk using a lactation model algorithm integrated within a physiologically based pharmacokinetic model. Pansari A; Faisal M; Jamei M; Abduljalil K Biopharm Drug Dispos; 2022 Oct; 43(5):201-212. PubMed ID: 36209366 [TBL] [Abstract][Full Text] [Related]
11. Maternal Ezetimibe Concentrations Measured in Breast Milk and Its Use in Breastfeeding Infant Exposure Predictions. Yeung CHT; Autmizguine J; Dalvi P; Denoncourt A; Ito S; Katz P; Rahman M; Theoret Y; Edginton AN Clin Pharmacokinet; 2024 Mar; 63(3):317-332. PubMed ID: 38278872 [TBL] [Abstract][Full Text] [Related]
12. Clinical lactation studies and the role of pharmacokinetic modeling and simulation in predicting drug exposures in breastfed infants. Anderson PO; Momper JD J Pharmacokinet Pharmacodyn; 2020 Aug; 47(4):295-304. PubMed ID: 32034606 [TBL] [Abstract][Full Text] [Related]
13. Oral galactagogues (natural therapies or drugs) for increasing breast milk production in mothers of non-hospitalised term infants. Foong SC; Tan ML; Foong WC; Marasco LA; Ho JJ; Ong JH Cochrane Database Syst Rev; 2020 May; 5(5):CD011505. PubMed ID: 32421208 [TBL] [Abstract][Full Text] [Related]
14. Dietary supplements for the lactating mother: influence on the trace element content of milk. Chierici R; Saccomandi D; Vigi V Acta Paediatr Suppl; 1999 Aug; 88(430):7-13. PubMed ID: 10569217 [TBL] [Abstract][Full Text] [Related]
15. Physiologically based pharmacokinetic model to predict drug concentrations of breast cancer resistance protein substrates in milk. Zhang T; Zou P; Fang Y; Li Y Biopharm Drug Dispos; 2022 Dec; 43(6):221-232. PubMed ID: 36265038 [TBL] [Abstract][Full Text] [Related]
16. Predicting Escitalopram Exposure to Breastfeeding Infants: Integrating Analytical and In Silico Techniques. Delaney SR; Malik PRV; Stefan C; Edginton AN; Colantonio DA; Ito S Clin Pharmacokinet; 2018 Dec; 57(12):1603-1611. PubMed ID: 29651785 [TBL] [Abstract][Full Text] [Related]
17. Determining the exposure of maternal medicines through breastfeeding: the UmbrelLACT study protocol-a contribution from the ConcePTION project. Van Neste M; Nauwelaerts N; Ceulemans M; Van Calsteren K; Eerdekens A; Annaert P; Allegaert K; Smits A BMJ Paediatr Open; 2024 Apr; 8(1):. PubMed ID: 38599799 [TBL] [Abstract][Full Text] [Related]
18. A comprehensive review on non-clinical methods to study transfer of medication into breast milk - A contribution from the ConcePTION project. Nauwelaerts N; Deferm N; Smits A; Bernardini C; Lammens B; Gandia P; Panchaud A; Nordeng H; Bacci ML; Forni M; Ventrella D; Van Calsteren K; DeLise A; Huys I; Bouisset-Leonard M; Allegaert K; Annaert P Biomed Pharmacother; 2021 Apr; 136():111038. PubMed ID: 33526310 [TBL] [Abstract][Full Text] [Related]
19. Mother And late Preterm Lactation Study (MAPLeS): a randomised controlled trial testing the use of a breastfeeding meditation by mothers of late preterm infants on maternal psychological state, breast milk composition and volume, and infant behaviour and growth. Dib S; Wells JCK; Fewtrell M Trials; 2020 Apr; 21(1):318. PubMed ID: 32264947 [TBL] [Abstract][Full Text] [Related]